Prolonged exposure to light and extreme temperatures may fade or change the color of the medication and may result in the medication being unsafe to use
Dose-finding RCT of diabetic patients (N = 1210) given either GLP1/GIP medication weekly or PC: After 68 weeks, mean weight loss was 10% ( GLP1/GIP medication ), 7% (lower dose GLP1/GIP medication ), and 3% (PC)
This ongoing evaluation not only aids in achieving weight loss goals but also addresses the question of whether compound tirzepatide is safe and effective over time
In clinical trials, patients taking Ozempic also showed significant reductions in cardiovascular problems such as heart attacks and strokes, even those without diabetes, or before weight loss started, said Duke University cardiologist and researcher Nishant Shah
Studies in animal models have demonstrated that it can improve learning and memory and reduce the rate of cognitive decline associated with ageing
The primary goal is to maintain a healthy lifestyle